🔎 Trials Near Me

Home › Diabetes › NCT06965803

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

RecruitingObservational study

Continuous Glucose Monitor (CGM) Discharge Program

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* aged 18 or older
* diagnosed with Type 1 or Type 2 Diabetes who are on insulin
* able to speak and understand English language
* scheduled to receive a standard inpatient diabetes education consultation
* must not have used CGM in the six months prior to admission
* owns a smartphone
* demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

Exclusion Criteria:

* those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
* non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

About the study

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Sponsor: Cedars-Sinai Medical Center · Participants: 37 · Started: Oct 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06965803

Locations in the U.S.

CaliforniaCedars-Sina Medical Center, Los Angeles

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.